Antezano Eduardo S, Hong Mauricio
Division of Cardiology, M/C 7872, University of Texas Health Science Center, San Antonio, TX 78229, USA.
J Intensive Care Med. 2003 Nov-Dec;18(6):313-29. doi: 10.1177/0885066603258140.
Sudden cardiac death (SCD) due to ventricular tachyarrhythmias is a leading cause of death in the United States. This phenomenon is associated with coronary artery disease, valvular heart disease, nonischemic cardiomyopathies, congenital heart disease, primary electrical abnormalities, autonomic nervous system abnormalities, and other less common disorders. Evaluation and management of patients at risk for SCD (primary prevention) and of patients who have survived at least 1 episode of SCD (secondary prevention) have evolved in recent years because clinical trials have shown consistent benefit from implantation of cardioverter-defibrillators in appropriately selected patients. An evidence-based approach to primary and secondary prevention of SCD is presented.
室性快速心律失常导致的心脏性猝死（SCD）是美国主要的死亡原因。这种现象与冠状动脉疾病、心脏瓣膜病、非缺血性心肌病、先天性心脏病、原发性电异常、自主神经系统异常以及其他较罕见的疾病有关。近年来，对SCD风险患者（一级预防）和至少经历过1次SCD发作的存活患者（二级预防）的评估和管理有所发展，因为临床试验表明，在适当选择的患者中植入心脏复律除颤器具有持续的益处。本文介绍了一种基于证据的SCD一级和二级预防方法。
